Meenakshi Khatta, MS, CRNP; Barbara S. Alexander, MD, PhD; Cathy M. Krichten, MS, CRNP; Michael L. Fisher, MD; Ronald Freudenberger, MD; Shawn W. Robinson, MD; Stephen S. Gottlieb, MD
Khatta M, Alexander BS, Krichten CM, Fisher ML, Freudenberger R, Robinson SW, et al. The Effect of Coenzyme Q10 in Patients with Congestive Heart Failure. Ann Intern Med. 2000;132:636-640. doi: 10.7326/0003-4819-132-8-200004180-00006
Download citation file:
Published: Ann Intern Med. 2000;132(8):636-640.
Coenzyme Q10 is commonly used to treat congestive heart failure on the basis of data from several unblinded, subjective studies. Few randomized, blinded, controlled studies have evaluated objective measures of cardiac performance.
To determine the effect of coenzyme Q10 on peak oxygen consumption, exercise duration, and ejection fraction.
Randomized, double-blind, controlled trial.
University and Veterans Affairs hospitals.
55 patients who had congestive heart failure with New York Heart Association class III and IV symptoms, ejection fraction less than 40%, and peak oxygen consumption less than 17.0 mL/kg per minute (orÂ <50% of predicted) during standard therapy were randomly assigned. Forty-six patients completed the study.
Coenzyme Q10, 200 mg/d, or placebo.
Left ventricular ejection fraction (measured by radionuclide ventriculography) and peak oxygen consumption and exercise duration (measured by a graded exercise evaluation using the Naughton protocol) with continuous metabolic monitoring.
Although the mean (Â±SD) serum concentration of coenzyme Q10 increased from 0.95 Â± 0.62 Âµg/mL to 2.2 Â± 1.2 Âµg/mL in patients who received active treatment, ejection fraction, peak oxygen consumption, and exercise duration remained unchanged in both the coenzyme Q10 and placebo groups.
Coenzyme Q10 does not affect ejection fraction, peak oxygen consumption, or exercise duration in patients with congestive heart failure receiving standard medical therapy.
Coenzyme Q had no overall effect. The mean ± SD is shown for each time point.
Circles represent patients who received active treatment, and crosses represent patients who received placebo. The study drug clearly increased serum concentrations of coenzyme Q . However, there was no relation between the change in serum concentration and the change in peak oxygen consumption.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Cardiac Diagnosis and Imaging, Cardiology, Heart Failure.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only